Compare DERM & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | USAU |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 214.2M |
| IPO Year | 2021 | 2020 |
| Metric | DERM | USAU |
|---|---|---|
| Price | $7.86 | $16.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $12.67 | ★ $22.83 |
| AVG Volume (30 Days) | ★ 200.6K | 195.1K |
| Earning Date | 05-13-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 36.11 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,858,000.00 | $17,402,000.00 |
| Revenue This Year | $39.72 | N/A |
| Revenue Next Year | $63.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $12.23 |
| 52 Week High | $9.56 | $23.72 |
| Indicator | DERM | USAU |
|---|---|---|
| Relative Strength Index (RSI) | 66.52 | 58.87 |
| Support Level | $7.25 | $16.35 |
| Resistance Level | $8.29 | $16.59 |
| Average True Range (ATR) | 0.39 | 0.71 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 85.50 | 69.18 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
U.S. Gold Corp is a gold, copper and precious metals development and exploration company pursuing exploration opportunities mainly in Wyoming, Nevada and Idaho. It is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada and the Challis Gold Project in Idaho. The company is engaged in the exploration and evaluation of its mineral properties, which is the single operating segment.